Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-23

FDA Approved: NEVIRAPINE — Supplemental Application (Micro Labs Limited)

View source ↗

Summary

FDA approved a supplemental application for nevirapine from Micro Labs Limited, enabling the availability of a generic nevirapine product for HIV-1 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEVIRAPINE (nevirapine)

Snippet

SUPPL AP for NEVIRAPINE (NEVIRAPINE)